Combined transfection of the three transcriptional factors, PDX-1, NeuroD1, and MafA, causes differentiation of bone marrow mesenchymal stem cells into insulin-producing cells
- PMID: 22761608
- PMCID: PMC3385644
- DOI: 10.1155/2012/672013
Combined transfection of the three transcriptional factors, PDX-1, NeuroD1, and MafA, causes differentiation of bone marrow mesenchymal stem cells into insulin-producing cells
Abstract
Aims: The goal of cell transcription for treatment of diabetes is to generate surrogate β-cells from an appropriate cell line. However, the induced replacement cells have showed less physiological function in producing insulin compared with normal β-cells.
Methods: Here, we report a procedure for induction of insulin-producing cells (IPCs) from bone marrow murine mesenchymal stem cells (BM-mMSCs). These BM-mMSCs have the potential to differentiate into insulin-producing cells when a combination of PDX-1 (pancreatic and duodenal homeobox-1), NeuroD1 (neurogenic differentiation-1), and MafA (V-maf musculoaponeurotic fibrosarcoma oncogene homolog A) genes are transfected into them and expressed in these cells.
Results: Insulin biosynthesis and secretion were induced in mMSCs into which these three genes have been transfected and expressed. The amount of induced insulin in the mMSCs which have been transfected with the three genes together is significantly higher than in those mMSCs that were only transfected with one or two of these three genes. Transplantation of the transfected cells into mice with streptozotocin-induced diabetes results in insulin expression and the reversal of the glucose challenge.
Conclusions: These findings suggest major implications for cell replacement strategies in generation of surrogate β-cells for the treatment of diabetes.
Figures









Similar articles
-
Differentiation of iPSCs into insulin-producing cells via adenoviral transfection of PDX-1, NeuroD1 and MafA.Diabetes Res Clin Pract. 2014 Jun;104(3):383-92. doi: 10.1016/j.diabres.2014.03.017. Epub 2014 Apr 1. Diabetes Res Clin Pract. 2014. PMID: 24794627
-
[Differentiation of polygene-modified bone marrow mesenchymal stem cells into insulin-producing cells].Zhonghua Yi Xue Za Zhi. 2011 Aug 16;91(30):2148-52. Zhonghua Yi Xue Za Zhi. 2011. PMID: 22093995 Chinese.
-
The study of regulatory effects of Pdx-1, MafA and NeuroD1 on the activity of porcine insulin promoter and the expression of human islet amyloid polypeptide.Mol Cell Biochem. 2014 Sep;394(1-2):59-66. doi: 10.1007/s11010-014-2081-8. Epub 2014 May 14. Mol Cell Biochem. 2014. PMID: 24825179
-
Combination of MafA, PDX-1 and NeuroD is a useful tool to efficiently induce insulin-producing surrogate beta-cells.Curr Med Chem. 2009;16(24):3144-51. doi: 10.2174/092986709788802980. Curr Med Chem. 2009. PMID: 19689288 Review.
-
PDX1, Neurogenin-3, and MAFA: critical transcription regulators for beta cell development and regeneration.Stem Cell Res Ther. 2017 Nov 2;8(1):240. doi: 10.1186/s13287-017-0694-z. Stem Cell Res Ther. 2017. PMID: 29096722 Free PMC article. Review.
Cited by
-
Stem Cell-Based Clinical Trials for Diabetes Mellitus.Front Endocrinol (Lausanne). 2021 Feb 26;12:631463. doi: 10.3389/fendo.2021.631463. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 33716982 Free PMC article. Review.
-
Differentiation of Human Adipose-Derived Mesenchymal Stromal/Stem Cells into Insulin-Producing Cells with A Single Tet-Off Lentiviral Vector System.Cell J. 2022 Dec 1;24(12):705-714. doi: 10.22074/cellj.2022.557533.1063. Cell J. 2022. PMID: 36527342 Free PMC article.
-
Mapping Mammalian Cell-type-specific Transcriptional Regulatory Networks Using KD-CAGE and ChIP-seq Data in the TC-YIK Cell Line.Front Genet. 2015 Nov 18;6:331. doi: 10.3389/fgene.2015.00331. eCollection 2015. Front Genet. 2015. PMID: 26635867 Free PMC article.
-
From Mesenchymal Stromal/Stem Cells to Insulin-Producing Cells: Immunological Considerations.Front Immunol. 2021 Jun 23;12:690623. doi: 10.3389/fimmu.2021.690623. eCollection 2021. Front Immunol. 2021. PMID: 34248981 Free PMC article. Review.
-
From Mesenchymal Stromal/Stem Cells to Insulin-Producing Cells: Progress and Challenges.Stem Cell Rev Rep. 2020 Dec;16(6):1156-1172. doi: 10.1007/s12015-020-10036-3. Stem Cell Rev Rep. 2020. PMID: 32880857 Free PMC article. Review.
References
-
- Best M, Carroll M, Hanley NA, Piper Hanley K. Embryonic stem cells to β-cells by understanding pancreas development. Molecular and Cellular Endocrinology. 2008;288(1-2):86–94. - PubMed
-
- Kim JH, Shin KH, Li TZ, Suh H. Potential of nucleofected human MSCs for insulin secretion. Journal of Tissue Engineering and Regenerative Medicine. 2011;5(10):761–769. - PubMed
-
- Li G, Luo R, Zhang J, et al. Generating mESC-derived insulin-producing cell lines through an intermediate lineage-restricted progenitor line. Stem Cell Research. 2009;2(1):41–55. - PubMed
-
- Naujok O, Francini F, Picton S, Bailey CJ, Lenzen S, Jörns A. Changes in gene expression and morphology of mouse embryonic stem cells on differentiation into insulin-producing cells in vitro and in vivo. Diabetes/Metabolism Research and Reviews. 2009;25(5):464–476. - PubMed
-
- Bernardo AS, Hay CW, Docherty K. Pancreatic transcription factors and their role in the birth, life and survival of the pancreatic β cell. Molecular and Cellular Endocrinology. 2008;294(1-2):1–9. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials